, Ces médicaments utilisés seuls ou en association peuvent exposer le patient à différents types d'infections ayant des répercussions buccales : -Infections fongiques et parasitaires

, Le développement d'infections parasitaires comme la leishmaniose et la toxoplasmose est également possible(92), vol.57, p.92

H. La-résurgence, Débutant par une sensation de brûlure au niveau labial, des vésicules disposées en bouquet apparaissent et laissent place à une macule érythémateuse au bout de 8 à 10 jours, Photo, vol.40

, L'application d'aciclovir en gel 4 à 6 fois par jour est suffisante si les épisodes sont peu fréquents. En cas de récurrence sévère, un traitement par aciclovir oral est indiqué (95)

, La varicelle peut également se développer et être rapidement extensive aux autres organes dans ce contexte

, En cas d'infection par le virus Epstein Barr, une plaque blanche striée par des plis verticaux, appelée leucoplasie orale chevelue, apparaît sur le bord latéral de la langue. Elle est généralement asymptomatique et ne nécessite pas de traitement, vol.40

, Le papillome est une prolifération bégnine liée à l'infection par le papillomavirus humain (HPV). Ces lésions sont traitées par exérèse chirurgicale, vol.40

. Orphanet, Sclérodermie systémique

B. Swynghedauw and . Sclérodermie, Arch Mal Coeur Vaiss -Prat, pp.35-41, 2009.

E. Puzenat, F. Aubin, H. P. Sclérodermie-systémique, and . Emc-dermatologie, , vol.5, pp.1-14, 2009.

J. Cabane, Critères de classification des sclérodermies, Presse Médicale, vol.35, issue.12, pp.1916-1938, 2006.

F. Van-den-hoogen, D. Khanna, J. Fransen, S. R. Johnson, M. Baron et al.,

, Classification Criteria for Systemic Sclerosis: An ACR-EULAR Collaborative Initiative, Arthritis Rheum, vol.65, issue.11, pp.2737-2784, 2013.

Y. Allanore, J. Wipff, A. Kahan, and C. Boileau, Génétique de la sclérodermie systémique, Rev Rhum, vol.74, issue.12, pp.1247-53, 2007.

D. Bessis, C. Francès, B. Guillot, and J. Guilhou, Manifestations dermatologiques des connectivites, vasculites et affections systémiques apparentées, 2006.

B. Granel, C. Chevillard, and A. Dessein, Facteurs de prédisposition génétiques à la fibrose au cours de la sclérodermie systémique, Rev Médecine Interne, vol.26, issue.4, pp.294-303, 2005.

J. Wipff, M. Giraud, J. Sibilia, L. Mouthon, O. Meyer et al., Polymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patients, J Rheumatol, vol.35, issue.4, pp.643-652, 2008.

J. Magnant and E. Diot, Sclérodermie systémique: épidémiologie et facteurs environnementaux, Presse Médicale, vol.35, issue.12, pp.1894-901, 2006.

I. Marie, J. F. Gehanno, A. Duval-modeste, P. Joly, S. Dominique et al.,

, Exposition au métaux lourds au cours de la sclérodermie systémique, Rev Médecine Interne, vol.37, p.123, 2016.

I. Marie and J. Gehanno, Environmental risk factors of systemic sclerosis, Semin Immunopathol, vol.37, issue.5, pp.463-73, 2015.

J. Gaultier, A. Hot, P. Cathébras, C. Grange, J. Ninet et al., Sclérodermie systémique chez l'homme, Rev Médecine Interne, vol.29, issue.3, pp.181-187, 2008.

, Groupe Francophone de Recherche sur la Sclérodermie, vol.18

&. Qu,

. Sclérodermie-systémique,

T. Yamamoto, Autoimmune mechanisms of scleroderma and a role of oxidative stress, Self/Nonself, vol.2, issue.1, pp.4-10, 2011.

A. Servettaz, C. Agard, M. C. Tamby, P. Guilpain, L. Guillevin et al.,

, Physiopathologie de la sclérodermie systémique: état des lieux sur une affection aux multiples facettes, Presse Médicale, vol.35, issue.12, pp.1903-1918, 2006.

L. Mouthon, Sclérodermie systémique : de la physiopathologie au traitement, Rev Médecine Interne, vol.28, pp.266-72, 2007.

Y. Allanore, J. Avouac, and A. Kahan, Systemic sclerosis: an update in 2008, Joint Bone Spine, vol.75, issue.6, pp.650-655, 2008.

M. Sticherling, Systemic sclerosis -dermatological aspects. Part 1: Pathogenesis, epidemiology, clinical findings, JDDG J Dtsch Dermatol Ges, vol.10, issue.10, pp.705-721, 2012.

S. M. Bongi, A. D. Rosso, I. Miniati, F. Galluccio, G. Landi et al., The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients, Rheumatol Int, vol.32, issue.9, pp.2785-90, 2012.

D. J. Fischer and L. L. Patton, Scleroderma: oral manifestations and treatment challenges, Spec Care Dentist, vol.20, issue.6, pp.240-244, 2000.

L. Mouthon, L'atteinte de la main dans la sclérodermie systémique, Presse Médicale, vol.42, issue.12, pp.1616-1642, 2013.

J. Avouac, A. Kahan, and Y. Allanore, Sclérodermie systémique : critères de diagnostic et de suivi, Rev Rhum, vol.77, issue.2, pp.103-107, 2010.

M. Hughes and A. L. Herrick, Raynaud's phenomenon, Best Pract Res Clin Rheumatol, vol.30, issue.1, pp.112-144, 2016.

N. Zbiti, S. Houssaini, T. Benkirane, A. Alhamany, Z. Rhou et al.,

, Crise rénale sclérodermique : un cas clinique, Néphrologie Thérapeutique, vol.6, issue.7, pp.606-615, 2010.

G. Bussone, L. H. Noël, and L. Mouthon, Manifestations rénales de la sclérodermie systémique, Nephrol Ther, vol.7, issue.3, pp.192-199, 2011.

S. Lori, M. Matucci-cerinic, R. Casale, S. Generini, A. Lombardi et al., Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure, Clin Exp Rheumatol, vol.14, issue.6, pp.601-606, 1996.

M. Baron, P. Lee, and E. C. Keystone, The articular manifestations of progressive systemic sclerosis (scleroderma), Ann Rheum Dis, vol.41, issue.2, pp.147-52, 1982.

N. Boutry, É. Hachulla, C. Zanetti-musielak, M. Morel, X. Demondion et al., Imaging features of musculoskeletal involvement in systemic sclerosis, Eur Radiol, vol.17, issue.5, pp.1172-80, 2007.

M. A. Omair, C. Pagnoux, H. Mcdonald-blumer, and J. Sr, Low Bone Density in Systemic Sclerosis. A Systematic Review, J Rheumatol, vol.40, issue.11, pp.1881-90, 2013.

B. Ranque, F. J. Authier, A. Berezne, L. Guillevin, and L. Mouthon, Systemic SclerosisAssociated Myopathy, Ann NY Acad Sci, vol.1108, issue.1, pp.268-82, 2007.

D. Sánchez-cano, N. Ortego-centeno, J. L. Callejas, F. Plá, V. Ríos-fernández et al., Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group, Rheumatol Int, vol.38, issue.3, pp.363-74, 2018.

D. Launay, P. D. Groote, V. Gaxotte, H. Charlanne, J. Beregi et al., Atteinte cardiaque de la sclérodermie systémique, MT Cardio, vol.2, issue.3, pp.339-54, 2006.

C. Ferri, D. Giuggioli, M. Sebastiani, M. Colaci, and M. Emdin, Heart involvement and systemic sclerosis, Lupus, vol.14, issue.9, pp.702-709, 2005.

S. Jung, T. Martin, M. Schmittbuhl, and O. Huck, The spectrum of orofacial manifestations in systemic sclerosis: a challenging management, Oral Dis, vol.23, issue.4, pp.424-463, 2017.

S. Ranjitkar, J. A. Kaidonis, and R. J. Smales, Gastroesophageal Reflux Disease and Tooth Erosion, Int J Dent, vol.2012, pp.1-10, 2012.

G. Isola, R. C. Williams, A. L. Gullo, L. Ramaglia, M. Matarese et al., Risk association between scleroderma disease characteristics, periodontitis, and tooth loss, Clin Rheumatol, vol.36, issue.12, pp.2733-2774, 2017.

V. Crincoli, L. Fatone, M. Fanelli, R. P. Rotolo, A. Chialà et al., Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study, Int J Mol Sci, vol.17, issue.7, p.1189, 2016.

G. Laskaris, L. Sueur-almosni, and F. , Atlas de poche des maladies buccales. Paris: Flammarion Médecine-Sciences, 2007.

M. Baron, M. Hudson, S. Tatibouet, R. Steele, E. Lo et al., The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population, Rheumatol Oxf Engl, vol.53, issue.8, pp.1386-94, 2014.

M. Dagenais, D. Macdonald, M. Baron, M. Hudson, S. Tatibouet et al., The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general population. Oral Surg Oral Med Oral Pathol Oral Radiol, vol.120, pp.104-115, 2015.

M. Baron, M. Hudson, S. Tatibouet, R. Steele, E. Lo et al., Relationship Between Disease Characteristics and Orofacial Manifestations in Systemic Sclerosis: Canadian Systemic Sclerosis Oral Health Study III, Arthritis Care Res, vol.67, issue.5, pp.681-90, 2015.

N. S. Norton, F. H. Netter, F. Duparc, and . Netter, Précis d'anatomie clinique de la tête et du cou, 2009.

G. Matarese, G. Isola, A. Alibrandi, A. Lo-gullo, G. Bagnato et al., Occlusal and MRI characterizations in systemic sclerosis patients: A prospective study from Southern Italian cohort, Joint Bone Spine, vol.83, issue.1, pp.57-62, 2016.

O. Ortega-hernandez and Y. Shoenfeld, Mixed connective tissue disease: An overview of clinical manifestations, diagnosis and treatment, Best Pract Res Clin Rheumatol, vol.26, issue.1, pp.61-72, 2012.

A. T. Masi, Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum. mai, vol.23, issue.5, pp.581-90, 1980.

E. C. Leroy and T. A. Medsger, Criteria for the classification of early systemic sclerosis, J Rheumatol, vol.28, issue.7, pp.1573-1579, 2001.

R. Foti, R. Leonardi, R. Rondinone, D. Gangi, M. Leonetti et al.,

, Scleroderma-like disorders, Autoimmun Rev, vol.7, issue.4, pp.331-340, 2008.

S. Deshayes, H. De-boysson, and L. Geffray, Les syndromes sclérodermiformes, Rev Médecine Interne, vol.37, issue.9, pp.616-640, 2016.

M. Fabri and N. Hunzelmann, Differential diagnosis of scleroderma and pseudoscleroderma, JDDG J Dtsch Dermatol Ges, vol.5, issue.11, pp.977-83

N. Hunzelmann, P. Moinzadeh, E. Genth, T. Krieg, W. Lehmacher et al.,

, High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy, Arthritis Res Ther, vol.11, issue.2, p.30, 2009.

C. P. Denton, Advances in pathogenesis and treatment of systemic sclerosis, Clin Med, vol.16, issue.1, pp.55-60, 2016.

M. Elhai, J. Avouac, A. Kahan, and Y. Allanore, Sclérodermie systémique : progrès récents, Rev Rhum, vol.82, issue.5, pp.291-298, 2015.

A. Bogus?awska-kapa?a, K. Ha?aburda, E. Rusyan, H. Go??bek, and I. Stru?ycka, Oral health of adult patients undergoing hematopoietic cell transplantation. Pre-transplant assessment and care, Ann Hematol. juill, vol.96, issue.7, pp.1135-1180, 2017.

O. Kowal-bielecka, J. Fransen, J. Avouac, M. Becker, A. Kulak et al., Update of EULAR recommendations for the treatment of systemic sclerosis, Ann Rheum Dis, vol.76, issue.8, pp.1327-1366, 2017.

A. Alantar, J. Cabane, E. Hachulla, G. Princ, D. Ginisty et al., V Recommendations for the care of oral involvement in patients with systemic sclerosis, Arthritis Care Res, vol.63, issue.8, pp.1126-1159, 2011.

F. Dost and C. S. Farah, Stimulating the discussion on saliva substitutes: a clinical perspective, Austral Dent J, vol.58, pp.11-17, 2013.

S. L. Tolle, Scleroderma: considerations for dental hygienists, Int J Dent Hyg. mai, vol.6, issue.2, pp.77-83, 2008.

J. Hamburger, Orofacial manifestations in patients with inflammatory rheumatic diseases, Best Pract Res Clin Rheumatol, vol.30, issue.5, pp.826-50, 2016.

J. W. Millsop, E. A. Wang, and N. Fazel, Etiology, evaluation, and management of xerostomia, Clin Dermatol, vol.35, issue.5, pp.468-76, 2017.

J. J. Napeñas, M. T. Brennan, and P. C. Fox, Diagnosis and treatment of xerostomia (dry mouth), Odontology, vol.97, issue.2, pp.76-83, 2009.

M. Cifuentes, P. D. Barrio-díaz, and C. Vera-kellet, Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial, Br J Dermatol, vol.179, issue.5, pp.1056-1061, 2018.

D. Sur, Saliwell. (page consultée le 17/01/19). Saliwell Dry Mouth Solutions

C. Farah, R. Ashman, and C. S. Candidosis, Clin Dermatol, vol.18, pp.553-562, 2000.

J. W. Mays, M. Sarmadi, and N. M. Moutsopoulos, Oral Manifestations of Systemic Autoimmune and Inflammatory Diseases: Diagnosis and Clinical Management, J Evid Based Dent Pract, vol.12, issue.3, pp.265-82, 2012.

J. O. Burgess and J. R. Gallo, Pierre Fabre Oral Care. (page consultée le 30/05/19), Dent Clin North Am, vol.46, issue.2, pp.385-404, 2002.

T. Donovan and E. Jr, Protocol for the Prevention and Management of Root Caries, J Esthet Restor Dent, vol.20, issue.6, pp.405-416, 2008.

R. J. Weyant, S. L. Tracy, T. Anselmo, ). Tracy, E. D. Beltrán-aguilar et al., Topical fluoride for caries prevention, J Am Dent Assoc, vol.144, issue.11, pp.1279-91, 2013.

V. Roy and C. Artaud, Scellements préventifs: Pourquoi ? Quand ? Comment ? Inform Dent, pp.2705-2716, 2001.

P. Sequeira-byron and A. Lussi, Prevention of root caries: Question: In patients at risk of VI root caries, is individualised oral hygiene instruction (OHI) every three months, OHI and applications of chlorhexidine varnish every three months, OHI and applications of sodium fluoride varnish every three months, or OHI and annual applications of silver diamine fluoride (SDF) solution most effective in preventing root caries? Evid Based Dent, vol.12, pp.70-71, 2012.

D. W. Banting, A. Papas, D. C. Clark, H. M. Proskin, M. Schultz et al., The effectiveness of 10% chlorhexidine varnish treatment on dental caries incidence in adults with dry mouth, Gerodontology, vol.17, issue.2, pp.67-76, 2000.

R. Gluzman, R. V. Katz, B. J. Frey, and R. Mcgowan, Prevention of root caries: a literature review of primary and secondary preventive agents, Spec Care Dentist, vol.33, issue.3, pp.133-173, 2013.

R. J. Wierichs and H. Meyer-lueckel, Systematic Review on Noninvasive Treatment of Root Caries Lesions, J Dent Res, vol.94, issue.2, pp.261-71, 2015.

. Société-française-de-chirurgie-orale, Prise en charge des foyers infectieux buccodentaires, Médecine Buccale Chir Buccale, vol.18, issue.3, pp.251-314, 2012.

, Agence Nationale de Sécurité du Médicament et des produits de santé. Prescription des antibiotiques en pratique bucco-dentaire, 2011.

R. P. Barron, R. P. Carmichael, M. A. Marcon, and G. Sàndor, Érosion dentaire et reflux gastro-oesophagien pathologique, vol.69, p.6, 2003.

A. Lussi and E. Hellwig, Risk assessment and Causal Preventive Measures, Monogr Oral Sci, vol.25, pp.220-229, 2014.

A. Lussi and E. Hellwig, Risk assessment and preventive measures, Monogr Oral Sci

K. Basel, , vol.20, pp.190-199, 2006.

T. Jaeggi, A. Gruninger, and A. Lussi, Restorative therapy of erosion, Monogr Oral Sci, vol.20, pp.200-214, 2006.

G. Pizzo, G. A. Scardina, and P. Messina, Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma, Clin Oral Investig, vol.7, issue.3, pp.175-183, 2003.

, Therabite ® Jaw Motion Rehabilitation System?

M. Gheisari, A. Ahmadzadeh, N. Nobari, B. Iranmanesh, N. Mozafari et al., Autologous fat grafting in the treatment of facial scleroderma. Dermatology Research and Practice, Case Rep Dermatol, vol.85, issue.2, pp.142-50, 2016.

K. Hoverson, T. Love, T. K. Lam, and J. D. Marquart, A novel treatment for limited mouth opening due to facial fibrosis: A case series, J Am Acad Dermatol, vol.78, issue.1, pp.190-192, 2018.

H. Mugino and K. Ikemura, Progressive Systemic Sclerosis With Spontaneous Fracture Due to Resorption of the Mandible: A Case Report, J Oral Maxillofac Surg, vol.64, issue.7, pp.1137-1146, 2006.

M. Sindou, Y. Keravel, E. Simon, and P. Mertens, Névralgie du trijumeau et Neurochirurgie. EMC-Neurologie, vol.2012, pp.1-14

A. Donnet, E. Simon, E. Cuny, G. Demarquay, A. Ducros et al., French Guidelines for diagnosis and treatment of classical trigeminal Neuralgia, Rev Neurol, vol.173, issue.3, pp.131-151, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01680822

C. Andrieux and P. Bidault, Hypertrophie gingivale médicamenteuse, Rev Odont Stomat, vol.46, pp.83-93, 2017.

J. G. Caton, G. Armitage, T. Berglundh, I. Chapple, S. Jepsen et al., A new classification scheme for periodontal and peri-implant diseases and conditionsIntroduction and key changes from the 1999 classification, J Clin Periodontol, vol.45, issue.S20, pp.1-8, 2018.

F. Campana, J. C. Fricain, and V. Sibaud, Toxicité buccale des médicaments, Paris: Edition CdP, 2016.

A. Yuan and S. Woo, Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol, vol.119, pp.35-47, 2015.

G. Deeming, J. Collingwood, and M. N. Pemberton, Methotrexate and oral ulceration, Br Dent J, vol.198, issue.2, pp.83-88, 2005.

R. Laurent, . Herpès, and . Emc--médecine, , vol.2, pp.265-75, 2005.

Y. Boucher and E. Cohen, Urgences dentaires et médicales. Rueil-Malmaison: Edition CdPWolters Kluwer France, 2007.